MiRXES Pte Ltd of Singapore at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

MiRXES Pte Ltd

2 Tukang Innovation Grove, #08-01 JTC MedTech Hub, 618305 Singapore
Telephone +65 68162931
Fax +65 68162930

This company is co-exhibitor of
Singapore Manufacturing Federation

Hall map

MEDICA 2018 hall map (Hall 3): stand G74

Fairground map

MEDICA 2018 fairground map: Hall 3


Dr Muhammad Tani Tabiin

Chief Operations Officer

Chng Yhee Cheng

Product Manager

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.02  Molecular biomarkers

Molecular biomarkers

Our products

Product category: Molecular biomarkers

MiRXES ID3EAL microRNA Assays

Gastric cancer early stage in-vitro diagnostic test. Best in class quantitative RT-qPCR life science reagents for detection of microRNAs as well as microRNA profiling services for healthcare and Agri-vet applications

More Less

About us

Company details

MiRXES has developed the best in class quantitative RT-PCR assay platform technology to detect microRNAs. All our microRNA assays are optimised and wet-lab validated. Coupled with multi-layer control measures, MiRXES technology delivers unparalleled sensitivity, specificity and reproducibility. 

MiRXES is able to detect more than 4 times the number of circulating microRNAs in biofluids compared to our closest competitors enabling MiRXES, our collaborators and customers to discover novel circulating microRNA biomarkers and develop these for early stage cancer diagnostics, companion diagnostics, prognostics for Cancer, Cardiovascular, Neuro and Metabolic Diseases among others as well as veterinary and ag-bio applications.

More Less